Search
for
Sort by
Research 391–420 of 1000+
- Aromatase deficiency in a male patient - Case report and review of the literature.
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Androgenetic alopecia and insulin resistance: are they truly associated?
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- Pharmacotherapy of polycystic ovary syndrome - an update
- Period problems: disorders of menstruation in adolescents
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Metabolic Syndrome Prevalence in Psoriasis
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Baldness, acne and testicular germ cell tumours
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
- Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Cardiometabolic profile of young women with hypoprolactinemia
- Parkinson's disease and skin
- Does a male polycystic ovarian syndrome equivalent exist?
- Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case–Control Study
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Obesity and the Polycystic Ovary Syndrome